Dynatronics Corporation (NASDAQ: DYNT) is one of 81 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it contrast to its competitors? We will compare Dynatronics Corporation to similar businesses based on the strength of its analyst recommendations, risk, institutional ownership, profitability, valuation, dividends and earnings.
Earnings and Valuation
This table compares Dynatronics Corporation and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Dynatronics Corporation||$35.76 million||-$1.86 million||-2.02|
|Dynatronics Corporation Competitors||$2.13 billion||$229.91 million||-32.54|
Dynatronics Corporation’s competitors have higher revenue and earnings than Dynatronics Corporation. Dynatronics Corporation is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This table compares Dynatronics Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Dynatronics Corporation Competitors||-311.23%||-29.41%||-9.92%|
This is a summary of recent recommendations for Dynatronics Corporation and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Dynatronics Corporation Competitors||266||1865||3346||108||2.59|
As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 7.23%. Given Dynatronics Corporation’s competitors higher probable upside, analysts clearly believe Dynatronics Corporation has less favorable growth aspects than its competitors.
Insider and Institutional Ownership
17.5% of Dynatronics Corporation shares are held by institutional investors. Comparatively, 51.1% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 51.8% of Dynatronics Corporation shares are held by company insiders. Comparatively, 18.7% of shares of all “Advanced Medical Equipment & Technology” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
Dynatronics Corporation has a beta of -0.14, meaning that its stock price is 114% less volatile than the S&P 500. Comparatively, Dynatronics Corporation’s competitors have a beta of 0.94, meaning that their average stock price is 6% less volatile than the S&P 500.
Dynatronics Corporation competitors beat Dynatronics Corporation on 6 of the 9 factors compared.
Dynatronics Corporation Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.
Receive News & Ratings for Dynatronics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.